KYMR – kymera therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Kymera Therapeutics, Inc. (NASDAQ: KYMR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $52.00 price target on the stock.
Kymera's Q4 Loss Wider Than Expected, Pipeline in Focus [Yahoo! Finance]
Kymera Therapeutics, Inc. (NASDAQ: KYMR) had its price target raised by analysts at HC Wainwright from $54.00 to $60.00. They now have a "buy" rating on the stock.
We're Not Very Worried About Kymera Therapeutics' (NASDAQ:KYMR) Cash Burn Rate [Yahoo! Finance]
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Form 4 Kymera Therapeutics, For: Mar 31 Filed by: Jacobs Bruce N.
Form 4 Kymera Therapeutics, For: Mar 03 Filed by: Gollob Jared
Form 4 Kymera Therapeutics, For: Mar 03 Filed by: Chiniara Ellen
Form 4 Kymera Therapeutics, For: Mar 03 Filed by: Jacobs Bruce N.
Form 4 Kymera Therapeutics, For: Mar 03 Filed by: Chadwick Jeremy G
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.